B. Dingle

1.5k total citations
18 papers, 408 citations indexed

About

B. Dingle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, B. Dingle has authored 18 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in B. Dingle's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Esophageal Cancer Research and Treatment (4 papers). B. Dingle is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Esophageal Cancer Research and Treatment (4 papers). B. Dingle collaborates with scholars based in Canada, United States and Japan. B. Dingle's co-authors include F. William Sunderman, Thomas R. Swift, Sidney M. Hopfer, R. Bryan Rumble, Melissa Brouwers, Jawaid Younus, Mark Vincent, George Rodrigues, Michael Sanatani and Brian Yaremko and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

B. Dingle

17 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Dingle Canada 9 156 138 100 59 52 18 408
Koichiro Kenzaki Japan 13 114 0.7× 276 2.0× 78 0.8× 61 1.0× 14 0.3× 42 578
Liqun Jia China 14 155 1.0× 149 1.1× 122 1.2× 91 1.5× 31 0.6× 68 717
Ying‐Hsiang Chou Taiwan 10 75 0.5× 61 0.4× 57 0.6× 17 0.3× 29 0.6× 53 409
Richard J. Kowalsky United States 10 55 0.4× 80 0.6× 34 0.3× 104 1.8× 18 0.3× 19 417
F Cefis Italy 10 66 0.4× 131 0.9× 78 0.8× 123 2.1× 33 0.6× 21 572
Kewei Wang China 13 94 0.6× 82 0.6× 72 0.7× 29 0.5× 28 0.5× 30 476
T. A. Sellers United States 9 252 1.6× 164 1.2× 16 0.2× 57 1.0× 15 0.3× 11 778
Heike Dally Germany 12 143 0.9× 49 0.4× 27 0.3× 171 2.9× 70 1.3× 18 600
Dejan Dragičević Serbia 17 45 0.3× 113 0.8× 213 2.1× 22 0.4× 29 0.6× 41 635
Konrad Pawełczyk Poland 14 196 1.3× 191 1.4× 55 0.6× 41 0.7× 5 0.1× 33 634

Countries citing papers authored by B. Dingle

Since Specialization
Citations

This map shows the geographic impact of B. Dingle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Dingle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Dingle more than expected).

Fields of papers citing papers by B. Dingle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Dingle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Dingle. The network helps show where B. Dingle may publish in the future.

Co-authorship network of co-authors of B. Dingle

This figure shows the co-authorship network connecting the top 25 collaborators of B. Dingle. A scholar is included among the top collaborators of B. Dingle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Dingle. B. Dingle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rodrigues, George, Alexander V. Louie, David A. Palma, et al.. (2018). Phase I Study of Concurrent and Consolidation Cisplatin and Docetaxel Chemotherapy with Thoracic Radiotherapy in Non-Small Cell Lung Cancer. Current Oncology. 25(1). 22–31. 2 indexed citations
2.
Yaremko, Brian, Douglas A. Hoover, Dante P. I. Capaldi, et al.. (2017). Functional Lung Avoidance for Individualized Radiation Therapy (FLAIR): Results of a Randomized, Double-Blind Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 99(2). E507–E507. 6 indexed citations
3.
Hoover, Douglas A., Dante P. I. Capaldi, Khadija Sheikh, et al.. (2014). Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial. BMC Cancer. 14(1). 934–934. 45 indexed citations
4.
Teft, Wendy A., Inna Y. Gong, B. Dingle, et al.. (2013). CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy. Breast Cancer Research and Treatment. 139(1). 95–105. 62 indexed citations
5.
Dingle, B. & Melissa Brouwers. (2012). The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer.
6.
Vincent, Mark, Stephen Welch, Denis Soulières, et al.. (2011). Randomized phase II trial of capecitabine (X) versus X plus erlotinib (E) in patients (pts) with metastatic colorectal cancer (mCRC): Differential impact of KRAS.. Journal of Clinical Oncology. 29(15_suppl). e14031–e14031. 1 indexed citations
7.
8.
Yu, Edward, Patricia Tai, Richard Malthaner, et al.. (2010). What Are the Factors that Predict Outcome at Relapse after Previous Esophagectomy and Adjuvant Therapy in High-Risk Esophageal Cancer?. Current Oncology. 17(6). 46–51. 7 indexed citations
9.
Wong, Rebecca, Scott Berry, Karen Spithoff, et al.. (2010). Preoperative or Postoperative Therapy for Stage II or III Rectal Cancer: An Updated Practice Guideline. Clinical Oncology. 22(4). 265–271. 47 indexed citations
10.
Yu, Edward, Patricia Tai, Jawaid Younus, et al.. (2009). Postoperative Extended-Volume External-Beam Radiation Therapy in High-Risk Esophageal Cancer Patients: A Prospective Experience. Current Oncology. 16(4). 48–54. 14 indexed citations
11.
Louie, Alexander V., George Rodrigues, Brian Yaremko, et al.. (2009). Management and Prognosis in Synchronous Solitary Resected Brain Metastasis from Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 10(3). 174–179. 37 indexed citations
12.
Yu, Edward, Patricia Tai, Jawaid Younus, et al.. (2007). Post-Operative Extended Volume External Beam Radiation Therapy Is Safe for High Risk Esophageal Cancer Patients. Scholarship@Western (Western University). 1 indexed citations
13.
Vincent, Mark, Ian G. Kerr, B. Dingle, Mary J. MacKenzie, & Michael Sanatani. (2007). Capecitabine (X) compared to X + erlotinib (E) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC): Interim efficacy results from a randomized phase II study. Journal of Clinical Oncology. 25(18_suppl). 14560–14560. 5 indexed citations
14.
Cripps, M. Christine, Mark Vincent, Derek J. Jonker, et al.. (2005). Dose reduced first-line capecitabine monotherapy in older and less fit patients with advanced colorectal cancer (ACRC). Journal of Clinical Oncology. 23(16_suppl). 3577–3577. 15 indexed citations
15.
Dingle, B., R. Bryan Rumble, & Melissa Brouwers. (2005). The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review. SHILAP Revista de lepidopterología. 19(12). 711–716. 46 indexed citations
16.
Yu, Eun‐Jeong, Patricia Tai, George Rodrigues, et al.. (2005). 150 Extended versus small field irradiation in high risk post esophagectomy patients receiving combined chemoradiation therapy: A decade experience in treatment of esophageal cancer. Radiotherapy and Oncology. 76. S45–S45. 1 indexed citations
17.
Sunderman, F. William, B. Dingle, Sidney M. Hopfer, & Thomas R. Swift. (1988). Acute nickel toxicity in electroplating workers who accidently ingested a solution of nickel sulfate and nickel chloride. American Journal of Industrial Medicine. 14(3). 257–266. 108 indexed citations
18.
Dingle, B., et al.. (1979). Hb Rainier or α2β2(145(HC2)Tyr → Cys) Observed in Members of a Canadian Family of Greek Origin. Hemoglobin. 3(2-3). 209–213. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichiro Kenzaki Breakdown of academic impact, for papers by Liqun Jia Breakdown of academic impact, for papers by Ying‐Hsiang Chou Breakdown of academic impact, for papers by Richard J. Kowalsky Breakdown of academic impact, for papers by F Cefis Breakdown of academic impact, for papers by Kewei Wang Breakdown of academic impact, for papers by T. A. Sellers Breakdown of academic impact, for papers by Heike Dally Breakdown of academic impact, for papers by Dejan Dragičević Breakdown of academic impact, for papers by Konrad Pawełczyk
Rankless by CCL
2026